Pharmacotherapy for OCD and Related Disorders

Pharmacotherapy for OCD and Related Disorders

Pharmacotherapy for OCD and Related Disorders

On this page

SSRIs in OCD - SSRI Superstars

  • First-line pharmacotherapy for OCD.
  • Mechanism: Serotonin reuptake inhibition.
  • Key: Higher doses & longer duration vs. depression.
    • Fluvoxamine: up to 300mg/day
    • Fluoxetine: 40-80mg/day
    • Sertraline: up to 200mg/day (can ↑ to 400mg)
    • Paroxetine: up to 60mg/day
    • Citalopram: 40-60mg/day (ECG if >40mg)
    • Escitalopram: 20-30mg/day (can ↑ to 40mg)
  • Full trial: 10-12 weeks at maximum tolerated dose.
  • Response: Gradual; counsel patience & adherence.
  • 📌 Mnemonic: For OCD, SSRIs Soar Higher, Linger Longer

⭐ SSRIs are first-line for OCD, often requiring higher doses (e.g., fluoxetine 40-80mg/day) and longer trial periods (at least 10-12 weeks at maximum tolerated dose) compared to their use in depression.

Clomipramine & Alternatives - TCA Titan & Tactics

  • Clomipramine (Anafranil): Tricyclic Antidepressant (TCA); potent Serotonin Reuptake Inhibitor (SRI).
    • Primary Use: OCD, especially severe or SSRI-refractory cases.
    • Dosage: Titrate slowly up to 250mg/day.
    • ⚠️ Critical Monitoring: Baseline and regular ECGs due to cardiotoxicity (QT prolongation, arrhythmias).
    • Common Side Effects:
      • Anticholinergic (dry mouth, constipation).
      • Antihistaminic (sedation, weight gain).
      • Orthostatic hypotension.
      • Lowers seizure threshold.
    • 📌 Mnemonic: "Clomi-prays-a-mean-serotonin-game, but watch the heart!"

⭐ Clomipramine, a tricyclic antidepressant, is often considered one of the most effective pharmacological treatments for OCD, but its use is limited by a greater side-effect burden compared to SSRIs.

Treatment-Resistant OCD - Augment & Attack

  • TR-OCD: Inadequate response to ≥2 SSRIs (adequate dose & duration, e.g., Fluoxetine up to 80mg/day for 12 weeks).
  • Augmentation Strategies (add to current SSRI):
    • Atypical Antipsychotics (APs):
      • Risperidone 0.5-2mg/day (most evidence)
      • Aripiprazole 2-10mg/day
      • Olanzapine, Quetiapine are alternatives.
    • Clomipramine: Potent SRI; add if not used or switch. Max dose 250mg/day.
    • Other options: Memantine, Ondansetron, Topiramate, N-acetylcysteine (NAC).
  • Non-pharmacological: Intensify CBT (Exposure and Response Prevention - ERP).

⭐ Augmentation of SSRIs with atypical antipsychotics (e.g., risperidone, aripiprazole) is an evidence-based strategy for treatment-resistant OCD.

OCRDs Pharmacotherapy - Beyond Obsessions

  • Body Dysmorphic Disorder (BDD):
    • SSRIs first-line; higher doses often needed (similar to OCD).
  • Hoarding Disorder:
    • SSRIs, venlafaxine; modest efficacy. Augmentation often considered.
  • Trichotillomania & Excoriation Disorder:
    • N-acetylcysteine (600-3000 mg/day) promising as glutamatergic modulator.
    • Clomipramine; SSRIs less effective. Consider naltrexone.

⭐ While SSRIs are first-line for Body Dysmorphic Disorder (BDD), N-acetylcysteine (NAC) has shown promise as a glutamatergic modulator in Trichotillomania and Excoriation Disorder.

High‑Yield Points - ⚡ Biggest Takeaways

  • SSRIs are first-line for OCD; higher doses and longer trials (8-12 weeks) are often required.
  • Clomipramine (TCA) is highly effective for OCD, especially severe cases, but carries more side effects.
  • Augmentation with atypical antipsychotics (e.g., risperidone) is used for treatment-resistant OCD.
  • Body Dysmorphic Disorder (BDD) and Hoarding Disorder also respond to SSRIs, frequently needing higher doses.
  • For Trichotillomania/Excoriation Disorder, N-acetylcysteine or Habit Reversal Therapy (HRT) are preferred; SSRIs show limited efficacy.

Practice Questions: Pharmacotherapy for OCD and Related Disorders

Test your understanding with these related questions

Drug most useful in the treatment of obsessive compulsive disorder is

1 of 5

Flashcards: Pharmacotherapy for OCD and Related Disorders

1/9

Patients showing _____ behaviour have poor prognosis with exposure and response prevention in OCD

TAP TO REVEAL ANSWER

Patients showing _____ behaviour have poor prognosis with exposure and response prevention in OCD

hoarding

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial